Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations

References

• Aanouz, I., Belhassan, A., Khatabi, K. E., Lakhlifi, T., Idrissi, M. E., & Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations. Journal of Biomolecular Structure and Dynamics, 38, 1–12.
   PubMed Web of Science ®Google Scholar
• Abdelli, I., Hassani, F., Bekkel Brikci, S., & Ghalem, S. (2020). In silico study the inhibition of Angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from western Algeria. Journal of Biomolecular Structure and Dynamics, 38, 1–17.  https://doi.org/10.1080/07391102.2020.1763199
   PubMed Web of Science ®Google Scholar
• Al-Khafaji, K., Al-DuhaidahawiL, D., & Taskin Tok, T. (2020). Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 38, 1–11. doi: https://doi.org/10.1080/07391102.2020.1764392
   PubMed Web of Science ®Google Scholar
• Báez-Santos, Y. M., John, S. E. S., & Mesecar, A. D. (2015). The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Research, 115, 21–38. https://doi.org/https://doi.org/10.1016/j.antiviral.2014.12.015
   PubMed Web of Science ®Google Scholar
• Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005). The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. Journal of Virology, 79(24), 15189–15198. https://doi.org/https://doi.org/10.1128/JVI.79.24.15189-15198.2005
   PubMed Web of Science ®Google Scholar
• Bohra, N., Sasidharan, S., Raj, S., Balaji, S., & Saudagar, P. (2020). Utilising capsid proteins of poliovirus to design a multi-epitope based subunit vaccine by immunoinformatics approach. Molecular Simulation, 46(5), 419–428. https://doi.org/https://doi.org/10.1080/08927022.2020.1720916
   Web of Science ®Google Scholar
• Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 38, 1–14. doi: https://doi.org/10.1080/07391102.2020.1758788
   PubMed Web of Science ®Google Scholar
• Bosch, B. J., van der Zee, R., de Haan, C. A., & Rottier, P. J. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. Journal of Virology, 77(16), 8801–8811. https://doi.org/https://doi.org/10.1128/jvi.77.16.8801-8811.2003
   PubMed Web of Science ®Google Scholar
• Chakrabarty, A. M. (2016). Bacterial azurin in potential cancer therapy. Cell Cycle (Georgetown, Tex.), 15(13), 1665–1666. https://doi.org/https://doi.org/10.1080/15384101.2016.1179034
   PubMed Web of Science ®Google Scholar
• Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., Hayden, F. G., & Yuen, K.-Y. (2013). Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. The Journal of Infection, 67(6), 606–616. https://doi.org/https://doi.org/10.1016/j.jinf.2013.09.029
   PubMed Web of Science ®Google Scholar
• Chaudhari, A., Fialho, A. M., Ratner, D., Gupta, P., Hong, C. S., Kahali, S., Yamada, T., Haldar, K., Murphy, S., Cho, W., Chauhan, V. S., Das Gupta, T. K., & Chakrabarty, A. M. (2006). Azurin, Plasmodium falciparum malaria and HIV/AIDS: Inhibition of parasitic and viral growth by Azurin. Cell Cycle (Georgetown, Tex.).), 5(15), 1642–1648. https://doi.org/https://doi.org/10.4161/cc.5.15.2992
   PubMed Web of Science ®Google Scholar
• Cheng, V. C., Lau, S. K., Woo, P. C., & Yuen, K. Y. (2007). Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical Microbiology Reviews, 20(4), 660–694. https://doi.org/https://doi.org/10.1128/CMR.00023-07
   PubMed Web of Science ®Google Scholar
• Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. https://doi.org/https://doi.org/10.1002/jmv.25681
   PubMed Web of Science ®Google Scholar
• Chen, X., Yang, X., Zheng, Y., Yang, Y., Xing, Y., & Chen, Z. (2014). SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. Protein & Cell, 5(5), 369–381. https://doi.org/https://doi.org/10.1007/s13238-014-0026-3
   PubMed Web of Science ®Google Scholar
• Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Chinnasamy, S., Selvaraj, G., Kaushik, A. C., Kaliamurthi, S., Chandrabose, S., Singh, S. K., Thirugnanasambandam, R., Gu, K., & Wei, D. Q. (2019). Molecular docking and molecular dynamics simulation studies to identify potent AURKA inhibitors: Assessing the performance of density functional theory, MM-GBSA and mass action kinetics calculations. Journal of Biomolecular Structure and Dynamics, 37, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2019.1674695
   PubMedGoogle Scholar
• Chinnasamy, S., Selvaraj, G., Selvaraj, C., Kaushik, A. C., Kaliamurthi, S., Khan, A., Singh, S. K., & Wei, D. Q. (2020). Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2). International Journal of Biological Macromolecules, 144, 53–66. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2019.12.091
   PubMed Web of Science ®Google Scholar
• Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 38, 1–18.
   PubMed Web of Science ®Google Scholar
• de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., Perlman, S., Poon, L. L. M., Snijder, E. J., Stephens, G. M., Woo, P. C. Y., Zaki, A. M., Zambon, M., & Ziebuhr, J. (2013). Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. Journal of Virology, 87(14), 7790–7792. https://doi.org/https://doi.org/10.1128/JVI.01244-13
   PubMed Web of Science ®Google Scholar
• de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014). Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrobial Agents and Chemotherapy, 58(8), 4875–4884. https://doi.org/https://doi.org/10.1128/AAC.03011-14
   PubMed Web of Science ®Google Scholar
• Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009). The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nature Reviews. Microbiology, 7(3), 226–236. https://doi.org/https://doi.org/10.1038/nrmicro2090
   PubMed Web of Science ®Google Scholar
• Duncan, A. L., Robinson, A. J., & Walker, J. E. (2016). Cardiolipin binds selectively but transiently to conserved lysine residues in the rotor of metazoan ATP synthases. Proceedings of the National Academy of Sciences of the United States of America, 113(31), 8687–8692. https://doi.org/https://doi.org/10.1073/pnas.1608396113
   PubMed Web of Science ®Google Scholar
• Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., Johansen, L. M., Lear-Rooney, C. M., Glass, P. J., Hensley, L. E., & Frieman, M. B. (2014). Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy, 58(8), 4885–4893. https://doi.org/https://doi.org/10.1128/AAC.03036-14
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020a). Natural products may interfere with SARS-CoV-2 attachment to the host cell. Journal of Biomolecular Structure and Dynamics, 38, 1–16.
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020b). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 38, 1–15.
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A., & Azzam, E. B. (2020). Novel Guanosine Derivatives against MERS CoV polymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 38, 1–12.
   PubMed Web of Science ®Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 38, 1–12.
   PubMed Web of Science ®Google Scholar
• Enayatkhani, M., Hasaniazad, M., Faezi, S., Guklani, H., Davoodian, P., Ahmadi, N., Einakian, M. A., Karmostaji, A., & Ahmadi, K. (2020). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. Journal of Biomolecular Structure and Dynamics, 38, 1–19.
   PubMed Web of Science ®Google Scholar
• Garzon, J. I., Lopéz-Blanco, J. R., Pons, C., Kovacs, J., Abagyan, R., Fernandez-Recio, J., & Chacon, P. (2009). FRODOCK: A new approach for fast rotational protein-protein docking. Bioinformatics (Oxford, England), 25(19), 2544–2551. https://doi.org/https://doi.org/10.1093/bioinformatics/btp447
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 38, 1–11.
   PubMed Web of Science ®Google Scholar
• Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020). Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 38, 1–19.
   PubMed Web of Science ®Google Scholar
• Habault, J., & Poyet, J.-L. (2019). Recent advances in cell penetrating peptide-based anticancer therapies. Molecules, 24(5), 927. https://doi.org/https://doi.org/10.3390/molecules24050927
   PubMed Web of Science ®Google Scholar
• Harcourt, B. H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K. M., Smith, C. M., Rota, P. A., & Baker, S. C. (2004). Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. Journal of Virology, 78(24), 13600–13612. https://doi.org/https://doi.org/10.1128/JVI.78.24.13600-13612.2004
   PubMed Web of Science ®Google Scholar
• Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., & Mehrabi, M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 38, 1–13.
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Krüger, N., Mueller, M. A., Drosten, C., & Pöhlmann, S. (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv, 1–23.
   Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M. … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet , 395(10223), 497–506. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Islam, R., Parves, R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 38, 1–20.
   PubMed Web of Science ®Google Scholar
• Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of Potential Multi-Target-Directed Ligands by Targeting Host-specific SARS-CoV-2 Structurally Conserved Main Protease$. Journal of Biomolecular Structure and Dynamics, 38, 1–16.
   PubMed Web of Science ®Google Scholar
• Kalita, P., Lyngdoh, D. L., Padhi, A. K., Shukla, H., & Tripathi, T. (2019). Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach. International Journal of Biological Macromolecules, 138, 224–233. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2019.07.024
   PubMed Web of Science ®Google Scholar
• Kalita, P., Padhi, A., Zhang, K. Y., & Tripathi, T. (2020). Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Microbial Pathogenesis, 145, 104236. https://doi.org/https://doi.org/10.1016/j.micpath.2020.104236
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 38, 1–14.
   PubMed Web of Science ®Google Scholar
• Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 38, 1–10.
   PubMed Web of Science ®Google Scholar
• Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017). The ClusPro web server for protein–protein docking. Nature Protocols, 12(2), 255–278. https://doi.org/https://doi.org/10.1038/nprot.2016.169
   PubMed Web of Science ®Google Scholar
• Kumar, D., Kumari, K., Jayaraj, A., Kumar, V., Kumar, R. V., Dass, S. K., Chandra, R., & Singh, P. (2020). Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. Journal of Biomolecular Structure and Dynamics, 38, 1–14.
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & A. Lynn, (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations . Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., & Zhang, L. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 1–9.
   Web of Science ®Google Scholar
• Lau, S. K., Woo, P. C., Li, K. S., Huang, Y., Tsoi, H.-W., Wong, B. H., Wong, S. S., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005). Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences of the United States of America, 102(39), 14040–14045. https://doi.org/https://doi.org/10.1073/pnas.0506735102
   PubMed Web of Science ®Google Scholar
• Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., Lui, S. F., Szeto, C. C., Chung, S., & Sung, J. J. Y. (2003). A major outbreak of severe acute respiratory syndrome in Hong Kong. New England Journal of Medicine, 348(20), 1986–1994. https://doi.org/https://doi.org/10.1056/NEJMoa030685
   PubMed Web of Science ®Google Scholar
• Li, S.-W., Wang, C.-Y., Jou, Y.-J., Huang, S.-H., Hsiao, L.-H., Wan, L., Lin, Y.-J., Kung, S.-H., & Lin, C.-W. (2016). SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6. International Journal of Molecular Sciences, 17(5), 678. https://doi.org/https://doi.org/10.3390/ijms17050678
   PubMed Web of Science ®Google Scholar
• Lindner, H. A., Fotouhi-Ardakani, N., Lytvyn, V., Lachance, P., Sulea, T., & Ménard, R. (2005). The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. Journal of Virology, 79(24), 15199–15208. https://doi.org/https://doi.org/10.1128/JVI.79.24.15199-15208.2005
   PubMed Web of Science ®Google Scholar
• Lobo-Galo, N., Terrazas-López, M., Martínez-Martínez, A., & Díaz-Sánchez, Á. G. (2020). FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics, 38, 1–12.
   PubMed Web of Science ®Google Scholar
• Mittal, A., Sasidharan, S., Raj, S., Balaji, S., & Saudagar, P. (2020). Exploring the Zika Genome to Design a Potential Multiepitope Vaccine Using an Immunoinformatics Approach. International Journal of Peptide Research and Therapeutics, 26, 1–10.
   Web of Science ®Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 38, 1–6.
   PubMed Web of Science ®Google Scholar
• Naguleswaran, A., Fialho, A. M., Chaudhari, A., Hong, C. S., Chakrabarty, A. M., & Sullivan, W. J. (2008). Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1. Antimicrobial Agents and Chemotherapy, 52(2), 402–408. https://doi.org/https://doi.org/10.1128/AAC.01005-07
   PubMed Web of Science ®Google Scholar
• Nava, M. (2018). Implementing dimer metadynamics using gromacs. Journal of Computational Chemistry, 39(25), 2126–2132. https://doi.org/https://doi.org/10.1002/jcc.25386
   PubMed Web of Science ®Google Scholar
• Omrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014). Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study. The Lancet Infectious Diseases, 14(11), 1090–1095. https://doi.org/https://doi.org/10.1016/S1473-3099(14)70920-X
   PubMed Web of Science ®Google Scholar
• Padhi, A. K., Kalita, P., Zhang, K. Y., & Tripathi, T. (2020). High Throughput Designing and Mutational Mapping of RBD-ACE2 Interface Guide Non-Conventional Therapeutic Strategies for COVID-19. bioRxiv, 1–27.
   Google Scholar
• Pant, S., Singh, M., Ravichandiran, V., Murty, U., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 38, 1–15.
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Qi, R., Wei, G., Ma, B., & Nussinov, R. (2018). Replica Exchange Molecular Dynamics: A Practical Application Protocol with Solutions to Common Problems and a Peptide Aggregation and Self-Assembly Example. Methods in Molecular Biology., 1777, 101–119.
   PubMedGoogle Scholar
• Ramírez-Aportela, E., López-Blanco, J. R., & Chacón, P. (2016). FRODOCK 2.0: Fast protein-protein docking server. Bioinformatics (Oxford, England), 32(15), 2386–2388. https://doi.org/https://doi.org/10.1093/bioinformatics/btw141
   PubMed Web of Science ®Google Scholar
• Ratia, K., Kilianski, A., Baez-Santos, Y. M., Baker, S. C., & Mesecar, A. (2014). Structural basis for the ubiquitin-linkage specificity and deISGylating activity of SARS-CoV papain-like protease. PLoS Pathogens, 10(5), e1004113. https://doi.org/https://doi.org/10.1371/journal.ppat.1004113
   PubMed Web of Science ®Google Scholar
• Reusken, C. B., Haagmans, B. L., Müller, M. A., Gutierrez, C., Godeke, G.-J., Meyer, B., Muth, D., Raj, V. S., Vries, L. S.-D., Corman, V. M., Drexler, J.-F., Smits, S. L., El Tahir, Y. E., De Sousa, R., van Beek, J., Nowotny, N., van Maanen, K., Hidalgo-Hermoso, E., Bosch, B.-J. … Koopmans, M. P. G. (2013). Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. The Lancet Infectious Diseases, 13(10), 859–866. https://doi.org/https://doi.org/10.1016/S1473-3099(13)70164-6
   PubMed Web of Science ®Google Scholar
• Sarma, P., Shekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., & Dhibar, D. P. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 38, 1–9.
   PubMed Web of Science ®Google Scholar
• Sasidharan, S., & Saudagar, P. (2019). Biochemical and structural characterization of tyrosine aminotransferase suggests broad substrate specificity and a two-state folding mechanism in Leishmania donovani . FEBS Open Bio, 9(10), 1769–1783. https://doi.org/https://doi.org/10.1002/2211-5463.12715
   PubMed Web of Science ®Google Scholar
• Sasidharan, S., & Saudagar, P. (2020). Concerted motion of structure and active site charge is required for tyrosine aminotransferase activity in Leishmania parasite. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 232, 118133https://doi.org/https://doi.org/10.1016/j.saa.2020.118133
   PubMed Web of Science ®Google Scholar
• Selvaraj, C., Sakkiah, S., Tong, W., & Hong, H. (2018). Molecular dynamics simulations and applications in computational toxicology and nanotoxicology. Food Chem. Toxicol, 112, 495–506. https://doi.org/https://doi.org/10.1016/j.fct.2017.08.028
   PubMed Web of Science ®Google Scholar
• Selvaraj, C., Singh, P., & Singh, S. K. (2014). Investigations on the interactions of λphage-derived peptides against the SrtA mechanism in Bacillus anthracis . Applied Biochemistry and Biotechnology, 172(4), 1790–1806. https://doi.org/https://doi.org/10.1007/s12010-013-0641-0
   PubMed Web of Science ®Google Scholar
• Selvaraj, C., Singh, P., & Singh, S. K. (2014). Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: Comparative structure analysis of wild and mutant HTLV-1 PR. Journal of Molecular Recognition: JMR, 27(12), 696–706. https://doi.org/https://doi.org/10.1002/jmr.2395
   PubMed Web of Science ®Google Scholar
• Shafique, S., & Rashid, S. (2019). Structural basis of βTrCP1-associated GLI3 processing . Scientific Reports, 9(1), 6865https://doi.org/https://doi.org/10.1038/s41598-019-43392-3
   PubMedGoogle Scholar
• Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504. https://doi.org/https://doi.org/10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Shi, J., Wei, Z., & Song, J. (2004). Dissection Study on the Severe Acute Respiratory Syndrome 3C-like Protease reveals the critical role of the extra domain in dimerization of the enzyme: Defining the extra domain as a new target for design of highly specific protease inhibitors. The Journal of Biological Chemistry, 279(23), 24765–24773. https://doi.org/https://doi.org/10.1074/jbc.M311744200
   PubMed Web of Science ®Google Scholar
• Shukla, R., Chetri, P. B., Sonkar, A., Pakharukova, M. Y., Mordvinov, V. A., & Tripathi, T. (2018). Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation. Journal of Biomolecular Structure and Dynamics, 36(13), 3541–3556. https://doi.org/https://doi.org/10.1080/07391102.2017.1392897
   PubMed Web of Science ®Google Scholar
• Shukla, R., Shukla, H., & Tripathi, T. (2020). Structure-based discovery of phenyl-diketo acids derivatives as Mycobacterium tuberculosis malate synthase inhibitors. Journal of Biomolecular Structure and Dynamics, 38, 1–14.
   PubMedGoogle Scholar
• Shukla, R., Shukla, H., Kalita, P., Sonkar, A., Pandey, T., Singh, D. B., Kumar, A., & Tripathi, T. (2018). Identification of potential inhibitors of Fasciola gigantica thioredoxin1: Computational screening, molecular dynamics simulation, and binding free energy studies. Journal of Biomolecular Structure & Dynamics, 36(8), 2147–2162. https://doi.org/https://doi.org/10.1080/07391102.2017.1344141
   PubMed Web of Science ®Google Scholar
• Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020). An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics, 38, 1–13.
   PubMed Web of Science ®Google Scholar
• Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular & Molecular Immunology, 17(6), 613–618. https://doi.org/https://doi.org/10.1038/s41423-020-0400-4
   PubMed Web of Science ®Google Scholar
• Taylor, B. N., Mehta, R. R., Yamada, T., Lekmine, F., Christov, K., Chakrabarty, A. M., Green, A., Bratescu, L., Shilkaitis, A., Beattie, C. W., & Das Gupta, T. K. (2009). Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Research, 69(2), 537–546. https://doi.org/https://doi.org/10.1158/0008-5472.CAN-08-2932
   PubMed Web of Science ®Google Scholar
• Umesh, Kundu, D., Selvaraj, C., Singh, S. K. & Dubey, V. K. (2020).  Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics, 38, 1–9.
   PubMedGoogle Scholar
• Vajda, S., Yueh, C., Beglov, D., Bohnuud, T., Mottarella, S. E., Xia, B., Hall, D. R., & Kozakov, D. (2017). New additions to the ClusPro server motivated by CAPRI. Proteins, 85(3), 435–444. https://doi.org/https://doi.org/10.1002/prot.25219
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181(2), 281–292.e6. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 10(5), 766–788. https://doi.org/https://doi.org/10.1016/j.apsb.2020.02.008
   PubMed Web of Science ®Google Scholar
• Xia, S., Liu, Q., Wang, Q., Sun, Z., Su, S., Du, L., Ying, T., Lu, L., & Jiang, S. (2014). Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Research, 194, 200–210. https://doi.org/https://doi.org/10.1016/j.virusres.2014.10.007
   PubMed Web of Science ®Google Scholar
• Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., Hilgenfeld, R., Yuen, K. Y., Wong, L., Gao, G., Chen, S., Chen, Z., Ma, D., Bartlam, M., & Rao, Z. (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biology, 3(10), e324. https://doi.org/https://doi.org/10.1371/journal.pbio.0030324
   PubMed Web of Science ®Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/https://doi.org/10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England Journal of Medicine, 367(19), 1814–1820. https://doi.org/https://doi.org/10.1056/NEJMoa1211721
   PubMed Web of Science ®Google Scholar
• Zhong, N., Zhang, S., Zou, P., Chen, J., Kang, X., Li, Z., Liang, C., Jin, C., & Xia, B. (2008). Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain. Journal of Virology, 82(9), 4227–4234. https://doi.org/https://doi.org/10.1128/JVI.02612-07
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S., & Yuen, K.-Y. (2016). Coronaviruses - drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347. https://doi.org/https://doi.org/10.1038/nrd.2015.37
   PubMed Web of Science ®Google Scholar